The Heart Has Its Own Non-Opioid Receptor for Dynorphin That Standard Drugs Can't Touch
Rat heart membranes have a dynorphin A binding site that is not blocked by standard opioid ligands, is trypsin-sensitive, and inhibited by zinc and magnesium ions.
Quick Facts
What This Study Found
Rat heart has a non-opioid dynorphin A(1-13) binding site: Kd 285 nM, Bmax 215 pmol/mg protein. Trypsin-sensitive. Inhibited by Zn2+ and Mg2+. Standard opioid ligands do not compete.
Key Numbers
How They Did This
Membrane binding assays using tritiated dynorphin A(1-13) on rat heart membrane preparations. Competition studies with opioid and non-opioid ligands. Characterization with enzyme treatment and divalent cations.
Why This Research Matters
The heart responding to dynorphin through a non-opioid receptor means opioid peptides affect the heart in ways that standard opioid drugs cannot block or mimic. This could explain some cardiac effects of opioid peptides.
The Bigger Picture
If the heart has its own non-opioid dynorphin receptor, this could explain cardiac effects of opioid peptides that aren't mediated by standard opioid drugs. It also means there's an entirely unexplored drug target in the heart.
What This Study Doesn't Tell Us
In vitro binding study. Shows receptor presence but not function. The biological effects of activating this non-opioid site were not tested. Rat heart may differ from human.
Questions This Raises
- ?What cardiac functions does this non-opioid dynorphin receptor regulate?
- ?Could targeting this receptor treat heart conditions without affecting pain pathways?
Trust & Context
- Key Stat:
- Non-opioid receptor Standard opioid drugs cannot compete for this cardiac dynorphin binding site — it's a completely different receptor system
- Evidence Grade:
- Preliminary — in vitro binding study characterizing receptor pharmacology. Demonstrates existence but not biological function.
- Study Age:
- Published in 1993 (33 years ago). Non-opioid actions of opioid peptides continue to be an active research area.
- Original Title:
- Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
- Published In:
- Journal of molecular and cellular cardiology, 25(8), 983-91 (1993)
- Authors:
- Dumont, M, Lemaire, S
- Database ID:
- RPEP-00262
Evidence Hierarchy
Frequently Asked Questions
What is a non-opioid dynorphin receptor?
While dynorphin normally acts on kappa opioid receptors in the brain, this cardiac binding site is completely different — standard opioid drugs don't interact with it. It represents an unknown signaling system in the heart.
Why does the heart need its own dynorphin receptor?
Opioid peptides have effects on heart rate and blood pressure. A non-opioid cardiac receptor could mediate effects that are independent of the classical opioid pain system, potentially regulating heart function in ways we don't yet understand.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00262APA
Dumont, M; Lemaire, S. (1993). Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.. Journal of molecular and cellular cardiology, 25(8), 983-91.
MLA
Dumont, M, et al. "Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.." Journal of molecular and cellular cardiology, 1993.
RethinkPeptides
RethinkPeptides Research Database. "Characterization of non-opioid [3H]dynorphin A-(1-13) bindin..." RPEP-00262. Retrieved from https://rethinkpeptides.com/research/dumont-1993-characterization-of-nonopioid-3hdynorphin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.